Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1567

1.

Nutrition in Pancreatic Cancer: A Review.

Gärtner S, Krüger J, Aghdassi AA, Steveling A, Simon P, Lerch MM, Mayerle J.

Gastrointest Tumors. 2016 May;2(4):195-202. doi: 10.1159/000442873. Epub 2016 Jan 8. Review.

2.

PI3K signaling: A molecular pathway associated with acute hypophagic response during inflammatory challenges.

Borges BC, Elias CF, Elias LL.

Mol Cell Endocrinol. 2016 Jul 5. pii: S0303-7207(16)30236-2. doi: 10.1016/j.mce.2016.07.005. [Epub ahead of print]

PMID:
27389879
3.

Proteomic profiling of muscle fibre type shifting in neuromuscular diseases.

Dowling P, Murphy S, Ohlendieck K.

Expert Rev Proteomics. 2016 Jul 4. [Epub ahead of print]

PMID:
27376776
4.

Frailty in Advanced Heart Failure.

Joyce E.

Heart Fail Clin. 2016 Jul;12(3):363-74. doi: 10.1016/j.hfc.2016.03.006. Review.

PMID:
27371513
5.

Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.

Miyamoto Y, Hanna DL, Zhang W, Baba H, Lenz HJ.

Clin Cancer Res. 2016 Jun 23. pii: clincanres.0495.2016. [Epub ahead of print]

PMID:
27340276
6.

Differential effects of interleukin-6 and activin A in the development of cancer-associated cachexia.

Chen JL, Walton KL, Qian H, Colgan TD, Hagg A, Watt MJ, Harrison CA, Gregorevic P.

Cancer Res. 2016 Jun 21. pii: canres.3152.2015. [Epub ahead of print]

PMID:
27328730
7.

Cystatin C Falsely Underestimated GFR in a Critically Ill Patient with a New Diagnosis of AIDS.

Brown CS, Kashani KB, Clain JM, Frazee EN.

Case Rep Nephrol. 2016;2016:9349280. doi: 10.1155/2016/9349280. Epub 2016 May 17.

8.

Virus-associated haemophagocytic lymphohistiocytosis in a young Filipino man.

Yu MG, Chua J.

BMJ Case Rep. 2016 Jun 9;2016. pii: bcr2016214655. doi: 10.1136/bcr-2016-214655.

PMID:
27284096
9.

The 2015 ESPEN Sir David Cuthbertson lecture: Inflammation as the driving force of muscle wasting in cancer.

Argilés JM.

Clin Nutr. 2016 May 26. pii: S0261-5614(16)30104-2. doi: 10.1016/j.clnu.2016.05.010. [Epub ahead of print]

PMID:
27268093
10.

Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.

Musolino V, Palus S, Tschirner A, Drescher C, Gliozzi M, Carresi C, Vitale C, Muscoli C, Doehner W, von Haehling S, Anker SD, Mollace V, Springer J.

J Cachexia Sarcopenia Muscle. 2016 Apr 7. doi: 10.1002/jcsm.12116. [Epub ahead of print]

11.

Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi-continent study.

Tyrovolas S, Koyanagi A, Olaya B, Ayuso-Mateos JL, Miret M, Chatterji S, Tobiasz-Adamczyk B, Koskinen S, Leonardi M, Haro JM.

J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):312-21. doi: 10.1002/jcsm.12076. Epub 2015 Oct 7.

12.

Sarcopenia and mortality among a population-based sample of community-dwelling older adults.

Brown JC, Harhay MO, Harhay MN.

J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):290-8. doi: 10.1002/jcsm.12073. Epub 2015 Oct 15.

13.

MAP3K11/GDF15 axis is a critical driver of cancer cachexia.

Lerner L, Tao J, Liu Q, Nicoletti R, Feng B, Krieger B, Mazsa E, Siddiquee Z, Wang R, Huang L, Shen L, Lin J, Vigano A, Chiu MI, Weng Z, Winston W, Weiler S, Gyuris J.

J Cachexia Sarcopenia Muscle. 2015 Oct 29. doi: 10.1002/jcsm.12077. [Epub ahead of print]

14.

Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.

Martinelli GB, Olivari D, Re Cecconi AD, Talamini L, Ottoboni L, Lecker SH, Stretch C, Baracos VE, Bathe OF, Resovi A, Giavazzi R, Cervo L, Piccirillo R.

Oncogene. 2016 May 23. doi: 10.1038/onc.2016.153. [Epub ahead of print]

PMID:
27212031
15.

Preventive effects of electrical stimulation on inflammation-induced muscle mitochondrial dysfunction.

Tanaka K, Tanaka M, Takegaki J, Fujino H.

Acta Histochem. 2016 Jun;118(5):464-70. doi: 10.1016/j.acthis.2016.04.011. Epub 2016 May 18.

PMID:
27209425
16.

Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia.

Bohnert KR, Gallot YS, Sato S, Xiong G, Hindi SM, Kumar A.

FASEB J. 2016 May 20. pii: fj.201600250RR. [Epub ahead of print]

PMID:
27206451
17.

The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats.

Borner T, Loi L, Pietra C, Giuliano C, Lutz TA, Riediger T.

Am J Physiol Regul Integr Comp Physiol. 2016 Jul 1;311(1):R89-96. doi: 10.1152/ajpregu.00044.2016. Epub 2016 May 4.

PMID:
27147616
18.

Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.

Fukawa T, Yan-Jiang BC, Min-Wen JC, Jun-Hao ET, Huang D, Qian CN, Ong P, Li Z, Chen S, Mak SY, Lim WJ, Kanayama HO, Mohan RE, Wang RR, Lai JH, Chua C, Ong HS, Tan KK, Ho YS, Tan IB, Teh BT, Shyh-Chang N.

Nat Med. 2016 Jun;22(6):666-71. doi: 10.1038/nm.4093. Epub 2016 May 2.

PMID:
27135739
19.

Cachexia among US cancer patients.

Arthur ST, Van Doren BA, Roy D, Noone JM, Zacherle E, Blanchette CM.

J Med Econ. 2016 May 11:1-7. [Epub ahead of print]

PMID:
27100202
20.

Progesterone therapy for the treatment of non-cancer cachexia: a systematic review.

Taylor JK, Pendleton N.

BMJ Support Palliat Care. 2016 Apr 20. pii: bmjspcare-2015-001041. doi: 10.1136/bmjspcare-2015-001041. [Epub ahead of print] Review.

PMID:
27098973
Items per page

Supplemental Content

Loading ...
Write to the Help Desk